AMY FENENGA: Open Payments
NPI 1144297797 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,533 in 46 payments from 13 companies in 2025. Trend: 2023 $814 · 2024 $1,469 · 2025 $1,533
Food & beverage: $1,438Education: $95
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $269 |
| GENZYME CORPORATION | 4 | $240 |
| Janssen Biotech, Inc. | 8 | $207 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $146 |
| Galderma Laboratories, L.P. | 3 | $143 |
| Novartis Pharmaceuticals Corporation | 4 | $101 |
| ABBVIE INC. | 5 | $99 |
| UCB, Inc. | 3 | $97 |
| Arcutis Biotherapeutics, Inc. | 1 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $57 |
Products named: OTEZLA, DUPIXENT, TREMFYA, NEMLUVIO, Bimzelx, Zoryve, SKYRIZI, LIBTAYO.
Industry payments across FL — which companies pay providers there.
